A full-stack health monitoring platform, built on Empatica's legacy of wearable medical technology, real-time data collection and beautifully-designed digital biomarker visualization.
Talk to our teamThe Empatica Health Monitoring Platform combines an award-winning, state-of-the-art wearable, continuous data collection and transfer, and unprecedented flexibility. Access a vast range of raw sensor data and clinically validated digital biomarkers, collected remotely from everyday life.
Designed for the patient, enhanced for the scientist
All the data you need for your next research breakthrough
The Empatica Health Monitoring Platform is a full-stack research suite built on the capabilities of EmbracePlus and entirely created in-house, with dedicated software and cloud infrastructure designed for your real-world and academic research needs.
EmbracePlus continuously measures and records physiological parameters, which are sent via Bluetooth® to a dedicated mobile app
The Care or Care Lab App uses the phone’s internet connection to automatically transfer all data to the Empatica Cloud
The Cloud securely stores data and makes it available for review inside the dedicated portal, or for immediate access via direct download
The Care Portal allows you to manage your studies and access your data and digital biomarkers
Empower your research with the world’s smallest and most advanced wearable to combine PPG, Accelerometer, Gyroscope, Temperature, and EDA sensors.
More info
A dedicated software ecosystem consisting of a smartphone app and cloud-based Portal, for data transfer, visualization, and access.
More info
Seamlessly integrate our Platform into your existing clinical trial management system (CTMS), making site operations smoother and the study experience better.
More info
EmbracePlus is one of the few wearable devices that capture raw data, with no black box algorithms.
Take a closer look at the data
With EmbracePlus you can monitor vitals, activity, sleep, and more, thanks to Empatica's wide range of digital measures.
Explore our full rangeSensor modes are predefined configurations for EmbracePlus that enable the device to focus on collecting specific parameters that are key to your study. Talk to our team to find out how sensor modes can enhance the data collection capabilities of the Empatica Health Monitoring Platform.
Funded by the European Union’s Horizon 2020. Empatica has joined a consortium with lead researchers in Obstructive sleep apnea (OSA). The goal of the consortium is to introduce a revolutionary approach based on machine learning to accurately diagnose OSA and provide optimal treatment for patients. With the help of EmbracePlus research suite, researchers and patients from across Europe are brought together under a single platform and work together to reach our common goal.
Funded by the European Union’s Horizon 2020. Despite the fact that adult attention-deficit / hyperactivity disorder (ADHD) is a common chronic condition among adults, with a high rate of ADHD patients also presenting various cardiometabolic conditions; our knowledge about this condition is lacking. Empatica has joined this consortium and is providing the EmbracePlus research suite to acquire new and unique real-world data using groundbreaking and advanced technology for continuous health monitoring to help develop ways to monitor ADHD and cardiometabolic symptoms and risks and eventually, contribute to optimized and personalized treatment approaches.
Empatica and Takeda collaborated to create a digital biomarker for Fabry Disease, a rare genetic disorder causing severe complications, the most common of which is absent or reduced sweating. Empatica’s EmbracePlus wearable was employed to explore the correlation between Electrodermal Activity (EDA) and sweat patterns. The data was used to develop an algorithm that could accurately distinguish low and high sweating subjects with a sensitivity of 77.27% and a specificity of 75.86%.
The Empatica Health Monitoring Platform can be purchased with two different plans: Academic & Basic Research or Enterprise. In the below table it is possible to check the differences between the two plans. Our Academic & Basic Research plan is designed with smaller study needs in mind, while the Enterprise plan is suited to large-scale clinical trials, with a large range of dedicated services to help you make the most of the Platform.
Legal notice: EmbracePlus is FDA-cleared as part of the Empatica Health Monitoring Platform. The Care Lab app and Care Lab Portal are intended for research use only and should not be used as part of diagnostic or clinical procedures.
Wondering if our solutions and digital biomarkers fit your needs?Reach out and a member of our team will be in touch with you as soon as possible.
Talk to our team
